| Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline G Raghu, M Remy-Jardin, JL Myers, L Richeldi, CJ Ryerson, DJ Lederer, ... American journal of respiratory and critical care medicine 198 (5), e44-e68, 2018 | 3528 | 2018 |
| Nintedanib in progressive fibrosing interstitial lung diseases KR Flaherty, AU Wells, V Cottin, A Devaraj, SLF Walsh, Y Inoue, ... New England Journal of Medicine 381 (18), 1718-1727, 2019 | 2049 | 2019 |
| Diagnosis of hypersensitivity pneumonitis in adults: an official ATS/JRS/ALAT clinical practice guideline G Raghu, M Remy-Jardin, CJ Ryerson, JL Myers, M Kreuter, M Vasakova, ... American journal of respiratory and critical care medicine 202 (3), e36-e69, 2020 | 851 | 2020 |
| Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study RA Evans, HJC McAuley, EM Harrison, A Shikotra, A Singapuri, M Sereno, ... The Lancet Respiratory Medicine 9 (11), 1275-1287, 2021 | 584 | 2021 |
| European respiratory society, Japanese respiratory society, and latin American thoracic society. Diagnosis of idiopathic pulmonary fibrosis. An official ATS G Raghu, M Remy-Jardin, JL Myers, L Richeldi, CJ Ryerson, DJ Lederer ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med 2018 198 …, 2018 | 535* | 2018 |
| Hypersensitivity pneumonitis: perspectives in diagnosis and management M Vasakova, F Morell, S Walsh, K Leslie, G Raghu American journal of respiratory and critical care medicine 196 (6), 680-689, 2017 | 497 | 2017 |
| Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort study SLF Walsh, AU Wells, SR Desai, V Poletti, S Piciucchi, A Dubini, H Nunes, ... The lancet Respiratory medicine 4 (7), 557-565, 2016 | 462 | 2016 |
| Quadriceps wasting and physical inactivity in patients with COPD D Shrikrishna, M Patel, RJ Tanner, JM Seymour, BA Connolly, ... European Respiratory Journal 40 (5), 1115-1122, 2012 | 403 | 2012 |
| Deep learning for classifying fibrotic lung disease on high-resolution computed tomography: a case-cohort study SLF Walsh, L Calandriello, M Silva, N Sverzellati The Lancet Respiratory Medicine 6 (11), 837-845, 2018 | 359 | 2018 |
| Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study RA Evans, OC Leavy, M Richardson, O Elneima, HJC McAuley, ... The Lancet Respiratory Medicine 10 (8), 761-775, 2022 | 358 | 2022 |
| Transbronchial cryobiopsies for the diagnosis of diffuse parenchymal lung diseases: expert statement from the cryobiopsy working group on safety and utility and a call for … J Hetzel, F Maldonado, C Ravaglia, AU Wells, TV Colby, S Tomassetti, ... Respiration 95 (3), 188-200, 2018 | 352 | 2018 |
| Interobserver agreement for the ATS/ERS/JRS/ALAT criteria for a UIP pattern on CT SLF Walsh, L Calandriello, N Sverzellati, AU Wells, DM Hansell Thorax 71 (1), 45-51, 2016 | 311 | 2016 |
| Mortality prediction in idiopathic pulmonary fibrosis: evaluation of computer-based CT analysis with conventional severity measures J Jacob, BJ Bartholmai, S Rajagopalan, M Kokosi, A Nair, R Karwoski, ... European Respiratory Journal 49 (1), 2017 | 270 | 2017 |
| Identification of diagnostic criteria for chronic hypersensitivity pneumonitis. An International Modified Delphi Survey J Morisset, KA Johannson, KD Jones, PJ Wolters, HR Collard, SLF Walsh, ... American journal of respiratory and critical care medicine 197 (8), 1036-1044, 2018 | 242 | 2018 |
| The natural history of progressive fibrosing interstitial lung diseases KK Brown, FJ Martinez, SLF Walsh, VJ Thannickal, A Prasse, ... European Respiratory Journal 55 (6), 2020 | 240 | 2020 |
| Connective tissue disease related fibrotic lung disease: high resolution computed tomographic and pulmonary function indices as prognostic determinants SLF Walsh, N Sverzellati, A Devaraj, GJ Keir, AU Wells, DM Hansell Thorax 69 (3), 216-222, 2014 | 227 | 2014 |
| Design of the PF-ILD trial: a double-blind, randomised, placebo-controlled phase III trial of nintedanib in patients with progressive fibrosing interstitial lung disease KR Flaherty, KK Brown, AU Wells, E Clerisme-Beaty, HR Collard, V Cottin, ... BMJ open respiratory research 4 (1), e000212, 2017 | 222 | 2017 |
| Chronic hypersensitivity pneumonitis: high resolution computed tomography patterns and pulmonary function indices as prognostic determinants SLF Walsh, N Sverzellati, A Devaraj, AU Wells, DM Hansell European radiology 22, 1672-1679, 2012 | 211 | 2012 |
| An integrated clinicoradiological staging system for pulmonary sarcoidosis: a case-cohort study SLF Walsh, AU Wells, N Sverzellati, GJ Keir, L Calandriello, KM Antoniou, ... The Lancet Respiratory Medicine 2 (2), 123-130, 2014 | 210 | 2014 |
| A standardized diagnostic ontology for fibrotic interstitial lung disease. An international working group perspective CJ Ryerson, TJ Corte, JS Lee, L Richeldi, SLF Walsh, JL Myers, J Behr, ... American journal of respiratory and critical care medicine 196 (10), 1249-1254, 2017 | 202 | 2017 |